Table 4.
CON | MIT | HIT | PM2.5 | MIT + PM2.5 | HIT + PM2.5 | ANOVA (P value) | |
---|---|---|---|---|---|---|---|
Before | 120.3 ± 6.4 | 123.6 ± 23.0 | 127.2 ± 26.2 | 116.0 ± 22.4 | 104.8 ± 37.9 | 119.2 ± 27.4 | 0.789 |
4th week | 112.5 ± 19.5 | 96.2 ± 23.9 | 85.6 ± 13.7† | 104.8 ± 23.0 | 104.0 ± 14.8 | 99.2 ± 16.6 | 0.328 |
8th week | 102.5 ± 14.7 | 93.4 ± 14.7 | 96.0 ± 19.6 | 94.8 ± 15.2 | 96.2 ± 15.1 | 109.4 ± 22.0 | 0.652 |
12th week | 91.5 ± 21.3 | 74.0 ± 10.9§ | 80.7 ± 17.0† | 80.1 ± 8.8∗ | 77.2 ± 15.6 | 81.6 ± 4.0∗ | 0.458 |
Fasting glycaemia (mg·dL−1) expressed as mean ± standard deviation. CON: control group, received 10 μL saline daily, maintained sedentary. MIT: moderate intensity training group, received 10 μL saline daily. HIT: high intensity training group, received 10 μL saline daily. PM2.5: exposure group, received 5 μg of PM2.5 daily, maintained sedentary. MIT + PM2.5: moderate intensity training group, received 5 μg of PM2.5 daily. HIT + PM2.5: high intensity training group, received 5 μg of PM2.5 daily (n = 5-6 per group). Data analysed by two-way ANOVA followed by Tukey's multiple comparison test. There was an effect of time (P < 0.0001) and no effect of treatment (P = 0.422) or interaction between time and treatment (P = 0.791). The time effects are indicated as ∗P < 0.05, †P < 0.01, and §P < 0.001 versus initial body weight (“before” data) in each respective group.